<DOC>
	<DOCNO>NCT00394602</DOCNO>
	<brief_summary>The primary objective study : 1 . To assess preference cancer patient schedule receive chemoradiation caregiver control side-effects chemoradiation . 1 . To compare preference cancer patient healthy individual . 2 . To compare patient ' preference side-effects chemoradiation change time . 2 . To longitudinally assess quality life cancer patient schedule receive chemoradiation . 3 . To determine impact nausea vomit associate chemoradiation patient ' quality life evaluate potential change throughout duration chemoradiation treatment .</brief_summary>
	<brief_title>Chemoradiation-Induced Nausea Emesis : Quality Life</brief_title>
	<detailed_description>You interview perception side effect related chemoradiation treatment . The interview take 20 minute . You interview begin chemoradiation treatment , 3 week treatment start , first follow-up appointment chemoradiation treatment end . Chemoradiation type cancer treatment involve chemotherapy radiation therapy . You also receive packet 3 questionnaire complete different time treatment . The questionnaire include quality life survey ask physical , social , emotional well-being , self-report symptom evaluation ask whether experience particular side effect much bother , brief survey ask question anxiety distress . The questionnaire take 20 minute complete . The questionnaire packet give patient begin chemoradiation treatment , 3 week treatment start , last day treatment , first follow-up appointment chemoradiation treatment end . If time complete questionnaire , stamp , address envelop give mail complete packet back research team . Your participation research study 4-6 week chemoradiation treatment end . This investigational study . Up 208 individual ( 104 patient 104 caregiver ) take part study . All enrol M. D. Anderson .</detailed_description>
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<mesh_term>Stomach Neoplasms</mesh_term>
	<mesh_term>Nausea</mesh_term>
	<mesh_term>Uterine Cervical Neoplasms</mesh_term>
	<mesh_term>Endometrial Neoplasms</mesh_term>
	<mesh_term>Vulvar Neoplasms</mesh_term>
	<mesh_term>Anus Neoplasms</mesh_term>
	<criteria>1 . Patients receive 5 6week course chemoradiation abdominalpelvic tumor ( gastric cancer , gastroesophageal ( GE ) junction , pancreatic , cervix , vulvar , endometrial , anal ) use conventional fractionation [ ( 180cGy200cGy per day ) ] 2 . Patients receive concurrent abdominalpelvic radiation single agent combination cisplatin , paclitaxel , CPT11 , oxaliplatin 5FU , capecitabine , gemcitabine , bevacizumab ( Avastin ) . 3 . Patients must least 18 year age 4 . Controls must individual prior cancer diagnosis 5 . Controls must least 18 year age 6 . Controls must caregivers patient study 1 . Patients diagnosis cervix , endometrial , vulvar anal cancer 2 . Patients schedule receive chemoradiation treatment 3 . Patients least 18 year age 4 . Controls individual prior diagnosis cancer ( exception nonmelanoma skin cancer ) 5 . Controls individual least 18 year age</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Gastric Cancer</keyword>
	<keyword>Pancreatic Cancer</keyword>
	<keyword>Cervical Cancer</keyword>
	<keyword>Vulvar Cancer</keyword>
	<keyword>Endometrial Cancer</keyword>
	<keyword>Anal Cancer</keyword>
	<keyword>Quality Life</keyword>
	<keyword>Questionnaire</keyword>
	<keyword>Interview</keyword>
	<keyword>Emesis</keyword>
	<keyword>Nausea</keyword>
	<keyword>Survey</keyword>
</DOC>